Term ends no later than Nov 19, 2036 · Medium confidence
20-year base term ends Feb 3, 2036
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Feb 3, 2016
Nov 19, 2036
Jul 18, 2023
This patent's term runs 290 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 3, 2016, when application 15/014,500, the earliest non-provisional in its chain, was filed (this one was filed Jul 24, 2020) | Feb 3, 2036 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +290 days, USPTO patent term adjustment record | Nov 19, 2036 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Nov 19, 2036 | Medium confidence |
This family
| US 10,724,110 | In force Mar 2037 | Mar 2037 |
| US 11,702,708 | this patent no later than Nov 2036 | no later than Nov 2036 |
| US 12,173,374 | In force Feb 2036 | Feb 2036 |
| Application 18/947,751 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 30, 2020 Reel 54225, frame 37 | Locke, Devin; Szamel, Piotr | Seven Bridges Genomics Inc. | Assignment of Assignor's Interest |
| Mar 30, 2022 Reel 59554, frame 165 | Seven Bridges Genomics Inc. | Imperial Financial Services B.V. | Security Interest |
| May 24, 2022 Reel 60173, frame 792 | Imperial Financial Services B.V. | Seven Bridges Genomics Inc. | Release of Security Interest |
| May 24, 2022 Reel 60173, frame 803 | Seven Bridges Genomics Inc. | Imperial Financial Services B.V. | Security Interest |
| Aug 2, 2022 Reel 61055, frame 78 | Imperial Financial Services B.V. | Seven Bridges Genomics Inc. | Release of Security Interest |
| Aug 4, 2022 Reel 61084, frame 786 | Pieriandx, Inc.; Seven Bridges Genomics Inc. | Orbimed Royalty & Credit Opportunities III, LP | Security Interest |
| Oct 9, 2026 reel/frame not recorded | Orbimed Royalty & Credit Opportunities III, LP | Pieriandx, Inc. | Release of Security Interest |
| Oct 9, 2026 reel/frame not recorded | Orbimed Royalty & Credit Opportunities III, LP | Seven Bridges Genomics Inc. | Release of Security Interest |
| Oct 9, 2026 Reel 76676, frame 119 | Orbimed Royalty & Credit Opportunities III, LP | Pieriandx, Inc.; Seven Bridges Genomics Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 19, 2036. We will not guess the cap.